General Electric Jumps on Deal to Sell Biopharma Unit to Danaher
Shares of General Electric (GE) surged this morning after the company agreed to sell it’s biopharmaceutical business to Danaher (DHR) for $21 billion in cash and the assumption of some pension liabilities.
Already a member?
Login to see your Morning News Leader Trade Idea.
Not yet a member?
You can receive four timely bull-put credit spreads each market day by joining our InvestorsKeyhole Daily Trade Alerts Service. Our analysts scour the news looking for unusual options activity, how insiders are trading, and breaking news, and publish trades accordingly.
Become A Member
About General Electric Company
With historical ties to inventor Thomas Edison, General Electric was formed through the combination of two companies in 1892. Today, GE is known for its digital industrial offerings and massive installed base spread across a variety of products and services, including aircraft engines, gas turbines, steam turbines, wind turbines, locomotives, and LED lighting, among others. In its current form, the company focuses on aviation, healthcare, and power, but management announced corporate actions in 2018 that will make aviation, power, and renewable energy the primary areas of focus going forward.